Aino Kivikallio
Papers
1
Total Citations
6
H-Index
1
About
Aino Kivikallio is a leading researcher in oncologic imaging, with a primary focus on prostate cancer diagnostics. Her work centers on the comparative evaluation of advanced imaging modalities, particularly 18F-PSMA-1007 PET/CT and whole-body MRI, to improve the detection and staging of high-risk prostate cancer. Her most cited paper (2025, 6 citations) prospectively compares these techniques against histopathology as the gold standard, demonstrating her commitment to rigorous, clinically translatable research. Beyond lesion detection, Kivikallio’s contributions include correlating PSMA uptake on PET with immunohistochemical expression, bridging imaging and molecular pathology to enhance diagnostic specificity. Her work directly addresses critical challenges in urologic oncology—improving intraprostatic tumour localization and T-staging accuracy. While her citation count is early-stage, the high-impact journal placement and the study’s prospective, histopathology-referenced design underscore its significance. Kivikallio’s research is poised to influence clinical guidelines for prostate cancer imaging, offering a more precise, non-invasive pathway for treatment planning. Her dedication to multimodal imaging integration marks her as an emerging authority in precision oncology diagnostics.
Research Focus
Key Achievements
Top Papers
- 1